Clover Health’s Conrad Wai, CEO of Counterpart Health, sells $1.42M in stock
Conrad Wai, CEO of Counterpart Health, sold 300,000 shares of Clover Health Investments (CLOV) stock on September 15, 2026. The transaction was valued at $1.42 million and took place in multiple trades, with share prices fluctuating between $4.60 and $5.06. Mr. Wai adopted a Rule 10b5-1 trading plan for this sale on June 8, 2026.
Following the stock sale, Wai still holds 1,065,699 shares of Class A Common Stock, and indirectly owns 1,170,056 shares through a family trust he co-trusts. Clover Health reported strong third-quarter results, surpassing analysts' expectations, with adjusted earnings of $0.01 per share and revenue of $759.3 million. Needham reiterated its Buy rating on the stock, with a price target of $6.00, anticipating the 2025 and 2026 cohorts to greatly contribute to the company's long-term earnings potential.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- CSW Industrials CEO Armes sells $434,376 in common stock investing.com
